---
title: "Doximity upgraded at Leerink on quarterly results, growth trends"
date: "2025-02-07 17:39:48"
summary: "Leerink Partners upgraded Doximity (NYSE:DOCS) to outperform from market perform following the company's strong quarterly beat and guidance, as well as growth trends. The investment firm raised its price target to $90 from $60 (~54% upside based on Feb. 6 close). Analyst Michael Cherny wrote that \"we see the continuation..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/165090199/image_165090199.jpg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Leerink Partners upgraded Doximity (NYSE:[DOCS](https://seekingalpha.com/symbol/DOCS "Doximity, Inc.")) to outperform from market perform following the company's strong quarterly beat and [guidance](https://seekingalpha.com/news/4404802-doximity-jumps-21-quarterly-beats-bullish-revenue-guidance "guidance"), as well as growth trends.
* The investment firm raised its price target to $90 from $60 (~54% upside based on Feb. 6 close).
* Analyst Michael Cherny wrote that "we see the continuation of core growth trends, driven by better attach rates on early customer buys and the long-term portal expansion as driving an ongoing positive reversion cycle. This should drive consistent upside to EBITDA..."
* He added that new products and AI investments should also add to growth.
* Cherny noted that in fiscal 2025 Q3, newer products, such as point of care and formulary, grew more than 100% and drove 20% of new sales.

[seekalpha](https://seekingalpha.com/news/4405148-doximity-upgraded-leerink-quarterly-results-growth-trends)
